{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:07:25Z","timestamp":1776118045352,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG082642"],"award-info":[{"award-number":["R01AG082642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.urology.2026.01.033","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:35:46Z","timestamp":1769672146000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determining a Real-world Definition of Percutaneous Tibial Nerve Stimulation Induction Therapy in Medicare Beneficiaries With Overactive Bladder"],"prefix":"10.1016","volume":"210","author":[{"given":"Unwanaobong","family":"Nseyo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lufan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Crow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Shatkin-Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.\u00a0John","family":"Boscardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Suskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.01.033_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urology.2026.01.033_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urology.2026.01.033_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/bju.15040","article-title":"Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study","volume":"126","author":"Welk","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2026.01.033_bib4","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/nau.24965","article-title":"Third-line therapy for overactive bladder in the elderly: nuances and considerations","volume":"41","author":"Zillioux","year":"2022","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.01.033_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003985","article-title":"The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder","volume":"212","author":"Cameron","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.033_bib6","first-page":"S121","article-title":"Persistence with overactive bladder pharmacotherapy in a Medicaid population","volume":"11","author":"Shaya","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.urology.2026.01.033_bib7","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial","volume":"183","author":"Peters","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.033_bib8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2021.02.005","article-title":"Real-world compliance with percutaneous tibial nerve stimulation maintenance therapy in an American population","volume":"153","author":"Du","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.01.033_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.urology.2020.04.102","article-title":"Contemporary patterns of third-line treatments for privately insured individuals with overactive bladder in the United States","volume":"142","author":"Jiang","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.01.033_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12877-023-04106-7","article-title":"Challenges and opportunity in mobility among older adults - key determinant identification","volume":"23","author":"Maresova","year":"2023","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.urology.2026.01.033_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2020.04.109","article-title":"Racial and socioeconomic factors influence utilization of advanced therapies in commercially insured OAB patients: an analysis of over 800,000 OAB patients","volume":"142","author":"Syan","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.urology.2026.01.033_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/SPV.0000000000001683","article-title":"Minimally invasive overactive bladder therapy after prolapse surgery","volume":"32","author":"Shatkin-Margolis","year":"2025","journal-title":"Urogynecology"},{"key":"10.1016\/j.urology.2026.01.033_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urology.2026.01.033_bib14","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/gerona\/glz224","article-title":"Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the U.S. medicare data","volume":"75","author":"Kim","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urology.2026.01.033_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7326\/M13-2946","article-title":"Neighborhood socioeconomic disadvantage and 30-day rehospitalization: a retrospective cohort study","volume":"161","author":"Kind","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urology.2026.01.033_bib16","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1002\/nau.24474","article-title":"Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States","volume":"39","author":"Kraus","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.01.033_bib17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/nau.25448","article-title":"Percutaneous tibial neuromodulation initial therapy compliance and subsequent third-line treatment patterns","volume":"43","author":"Padmanabhan","year":"2024","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.01.033_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ajo.13822","article-title":"Percutaneous tibial nerve stimulation for the overactive bladder: a\u00a0single-arm trial","volume":"64","author":"Kyaw","year":"2024","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.urology.2026.01.033_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/nau.24254","article-title":"Long-term real-life adherence of percutaneous tibial nerve stimulation in over 400 patients","volume":"39","author":"Te Dorsthorst","year":"2020","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2026.01.033_bib20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.juro.2017.09.102","article-title":"Use of third line therapy for overactive bladder in a practice with multiple subspecialty providers-are we doing enough?","volume":"199","author":"Moskowitz","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.01.033_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.urology.2022.11.006","article-title":"National trends in third-line treatment for overactive bladder among commercially insured women, 2010-2019","volume":"175","author":"Edge","year":"2023","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:31:11Z","timestamp":1776115871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":21,"alternative-id":["S0090429526000683"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.01.033","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining a Real-world Definition of Percutaneous Tibial Nerve Stimulation Induction Therapy in Medicare Beneficiaries With Overactive Bladder","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}